Browsing Centre for Experimental Medicine and Rheumatology (EMR) by Author "Orr, C"
Now showing items 1-3 of 3
-
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology
Najm, A; Costantino, F; Alivernini, S; Alunno, A; Bianchi, E; Bignall, J; Boyce, B; Canete, JD; Carubbi, F; Durez, P (2022) -
Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.
Guo, Y; Walsh, AM; Canavan, M; Wechalekar, MD; Cole, S; Yin, X; Scott, B; Loza, M; Orr, C; McGarry, T (Public Library of Science, 2018-02-28)Immune checkpoint blockade with therapeutic anti-cytotoxic T lymphocyte-associated antigen (CTLA)-4 (Ipilimumab) and anti-programmed death (PD)-1 (Nivolumab and Pembrolizumab) antibodies alone or in combination has shown ... -
Synovial tissue research: a state-of-the-art review
Orr, C; Sousa, E; Boyle, DL; Buch, MH; Buckley, CD; Canete, JD; Catrina, AI; Choy, EHS; Emery, P; Fearon, U (2017-08)